Pfizer bid to expand Talzenna use in prostate cancer questioned by FDA panel

Pfizer's bid to expand prostate cancer drug Talzenna's usage faces FDA panel rejection

https://seekingalpha.com/news/4451333-pfizer-bid-expand-talzenna-use-prostate-cancer-questioned-fda-panel